Skip to content
10-Q

Quarterly Report

Progyny, Inc. PGNY

0001551306-25-000103

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 85.72M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $237.13M
Current Liabilities Q1 2025 · Dec 31, 2024 $168.63M
Total Liabilities Q1 2025 · Mar 31, 2025 $263.13M
Total Liabilities Q1 2025 · Dec 31, 2024 $185.04M
Current Assets Q1 2025 · Mar 31, 2025 $567.69M
Current Assets Q1 2025 · Dec 31, 2024 $472.72M
Total Assets Q1 2025 · Mar 31, 2025 $730.29M
Total Assets Q1 2025 · Dec 31, 2024 $607.1M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $162.31M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $114.96M
Shares Diluted Q1 2025 · Mar 31, 2024 101.05M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $23.76M
Capex Q1 2025 · Mar 31, 2024 $850K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $25.73M
Stockholders Equity Q1 2025 · Mar 31, 2024 $571.6M
Stockholders Equity Q1 2025 · Dec 31, 2023 $553.43M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.17
Eps Basic Q1 2025 · Mar 31, 2024 $0.18
Sga Expense Q1 2025 · Mar 31, 2024 $28.43M
Net Income Q1 2025 · Mar 31, 2024 $16.9M
Operating Income Q1 2025 · Mar 31, 2024 $18.52M
Gross Profit Q1 2025 · Mar 31, 2024 $62.41M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $215.67M
Revenue Q1 2025 · Mar 31, 2024 $278.08M